These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20688285)

  • 21. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C; Gupta V; Ahsan F
    Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.
    Singh M; Li XM; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Vaccine; 1997 Apr; 15(5):475-81. PubMed ID: 9160514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
    Saini V; Jain V; Sudheesh MS; Dixit S; Gaur RL; Sahoo MK; Joseph SK; Verma SK; Jaganathan KS; Murthy PK; Kohli D
    J Drug Target; 2010 Apr; 18(3):212-22. PubMed ID: 19883203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
    Jain AK; Goyal AK; Gupta PN; Khatri K; Mishra N; Mehta A; Mangal S; Vyas SP
    J Control Release; 2009 Jun; 136(2):161-9. PubMed ID: 19239919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer.
    Xu W; He J; Wu G; Xiong F; Du H; Wang G
    Int J Pharm; 2015 Dec; 496(2):332-41. PubMed ID: 26453785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
    He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
    J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle.
    Lee ES; Park KH; Park IS; Na K
    Int J Pharm; 2007 Jun; 338(1-2):310-6. PubMed ID: 17363202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells.
    Sahoo SK; Panda AK; Labhasetwar V
    Biomacromolecules; 2005; 6(2):1132-9. PubMed ID: 15762686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity.
    S KRN; Nishanth AN; R S AB; Nivedh K; Syed NH; R RS
    Int J Biol Macromol; 2020 Feb; 144():978-994. PubMed ID: 31669465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
    J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable cationic microparticles for enhanced model antigen delivery to dendritic cells.
    Wischke C; Borchert HH; Zimmermann J; Siebenbrodt I; Lorenzen DR
    J Control Release; 2006 Sep; 114(3):359-68. PubMed ID: 16889866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen.
    Nellore RV; Pande PG; Young D; Bhagat HR
    J Parenter Sci Technol; 1992; 46(5):176-80. PubMed ID: 1331390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
    He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
    J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.